Horiuchi M - Search Results

1

Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Suzuki J, Iwai M, Li Z, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M, Horiuchi M. Suzuki J, et al. Among authors: horiuchi m. J Hypertens. 2005 Jul;23(7):1383-9. doi: 10.1097/01.hjh.0000173521.91104.5f. J Hypertens. 2005. PMID: 15942461

2

Effect of estrogen and AT1 receptor blocker on neointima formation.

Liu HW, Iwai M, Takeda-Matsubara Y, Wu L, Li JM, Okumura M, Cui TX, Horiuchi M. Liu HW, et al. Among authors: horiuchi m. Hypertension. 2002 Oct;40(4):451-7; discussion 448-50. doi: 10.1161/01.hyp.0000033466.05496.89. Hypertension. 2002. PMID: 12364346

3

Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.

Horiuchi M, Cui TX, Li Z, Li JM, Nakagami H, Iwai M. Horiuchi M, et al. Circulation. 2003 Jan 7;107(1):106-12. doi: 10.1161/01.cir.0000043244.13596.20. Circulation. 2003. PMID: 12515751

4

Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.

Chen R, Iwai M, Wu L, Suzuki J, Min LJ, Shiuchi T, Sugaya T, Liu HW, Cui TX, Horiuchi M. Chen R, et al. Among authors: horiuchi m. Hypertension. 2003 Oct;42(4):542-7. doi: 10.1161/01.HYP.0000092440.52239.39. Epub 2003 Sep 8. Hypertension. 2003. PMID: 12963679

5

Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan.

Jinno T, Iwai M, Li Z, Li JM, Liu HW, Cui TX, Rakugi H, Ogihara T, Horiuchi M. Jinno T, et al. Among authors: horiuchi m. Hypertension. 2004 Feb;43(2):263-9. doi: 10.1161/01.HYP.0000113627.08110.6f. Epub 2004 Jan 5. Hypertension. 2004. PMID: 14707152

6

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.

Shiuchi T, Iwai M, Li HS, Wu L, Min LJ, Li JM, Okumura M, Cui TX, Horiuchi M. Shiuchi T, et al. Among authors: horiuchi m. Hypertension. 2004 May;43(5):1003-10. doi: 10.1161/01.HYP.0000125142.41703.64. Epub 2004 Mar 22. Hypertension. 2004. PMID: 15037562

7

Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis.

Li Z, Iwai M, Wu L, Liu HW, Chen R, Jinno T, Suzuki J, Tsuda M, Gao XY, Okumura M, Cui TX, Horiuchi M. Li Z, et al. Among authors: horiuchi m. Hypertension. 2004 Nov;44(5):758-63. doi: 10.1161/01.HYP.0000145179.44166.0f. Epub 2004 Sep 27. Hypertension. 2004. PMID: 15452025

8

Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells.

Li JM, Iwai M, Cui TX, Min LJ, Tsuda M, Iwanami J, Suzuki J, Mogi M, Horiuchi M. Li JM, et al. Among authors: horiuchi m. Mol Pharmacol. 2005 May;67(5):1666-73. doi: 10.1124/mol.104.008144. Epub 2005 Feb 4. Mol Pharmacol. 2005. PMID: 15695623

9

Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.

Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M. Tsuda M, et al. Among authors: horiuchi m. Hypertension. 2005 Apr;45(4):545-51. doi: 10.1161/01.HYP.0000157409.88971.fc. Epub 2005 Feb 21. Hypertension. 2005. PMID: 15723967

10

Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.

Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M. Min LJ, et al. Among authors: horiuchi m. Circ Res. 2005 Sep 2;97(5):434-42. doi: 10.1161/01.RES.0000180753.63183.95. Epub 2005 Aug 4. Circ Res. 2005. PMID: 16081869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,096 results

Search Page

Filters